Susquehanna International Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.8M | Sell |
99,600
-19,300
| -16% | -$3.37M | ﹤0.01% | 2306 |
|
|
2025
Q4 | $20.2M | Buy |
118,900
+12,200
| +11% | +$1.87M | ﹤0.01% | 2194 |
|
|
2025
Q3 | $14.1M | Buy |
106,700
+42,400
| +66% | +$5.09M | ﹤0.01% | 2581 |
|
|
2025
Q2 | $6.82M | Buy |
64,300
+7,500
| +13% | +$815K | ﹤0.01% | 3425 |
|
|
2025
Q1 | $7.05M | Buy |
56,800
+21,600
| +61% | +$2.82M | ﹤0.01% | 3026 |
|
|
2024
Q4 | $4.33M | Sell |
35,200
-46,300
| -57% | -$5.46M | ﹤0.01% | 3830 |
|
|
2024
Q3 | $9.08M | Buy |
81,500
+21,400
| +36% | +$2.35M | ﹤0.01% | 2755 |
|
|
2024
Q2 | $6.41M | Buy |
60,100
+11,000
| +22% | +$1.21M | ﹤0.01% | 3060 |
|
|
2024
Q1 | $5.91M | Sell |
49,100
-37,800
| -43% | -$4.63M | ﹤0.01% | 3378 |
|
|
2023
Q4 | $10.7M | Buy |
86,900
+78,600
| +947% | +$9.81M | ﹤0.01% | 2558 |
|
|
2023
Q3 | $1.07M | Sell |
8,300
-14,500
| -64% | -$1.93M | ﹤0.01% | 6471 |
|
|
2023
Q2 | $2.83M | Buy |
22,800
+7,700
| +51% | +$1.04M | ﹤0.01% | 4473 |
|
|
2023
Q1 | $2.21M | Sell |
15,100
-64,400
| -81% | -$9.53M | ﹤0.01% | 4926 |
|
|
2022
Q4 | $12.7M | Buy |
79,500
+13,900
| +21% | +$2.04M | ﹤0.01% | 1976 |
|
|
2022
Q3 | $8.74M | Buy |
65,600
+3,000
| +5% | +$456K | ﹤0.01% | 2358 |
|
|
2022
Q2 | $9.77M | Sell |
62,600
-8,600
| -12% | -$1.32M | ﹤0.01% | 2226 |
|
|
2022
Q1 | $11.1M | Sell |
71,200
-80,200
| -53% | -$11.6M | ﹤0.01% | 2422 |
|
|
2021
Q4 | $19.5M | Sell |
151,400
-16,900
| -10% | -$2.22M | ﹤0.01% | 1876 |
|
|
2021
Q3 | $21.9M | Sell |
168,300
-86,700
| -34% | -$13.1M | ﹤0.01% | 1881 |
|
|
2021
Q2 | $46.7M | Buy |
255,000
+82,500
| +48% | +$14.3M | 0.01% | 1246 |
|
|
2021
Q1 | $28.4M | Buy |
172,500
+106,800
| +163% | +$17.6M | ﹤0.01% | 1522 |
|
|
2020
Q4 | $10.8M | Sell |
65,700
-145,100
| -69% | -$21.6M | ﹤0.01% | 2403 |
|
|
2020
Q3 | $30.1M | Buy |
210,800
+88,800
| +73% | +$11M | 0.01% | 1174 |
|
|
2020
Q2 | $13.5M | Buy |
122,000
+100,900
| +478% | +$11.2M | ﹤0.01% | 1813 |
|
|
2020
Q1 | $2.1M | Sell |
21,100
-28,200
| -57% | -$3.65M | ﹤0.01% | 3885 |
|
|
2019
Q4 | $7.36M | Sell |
49,300
-22,500
| -31% | -$3.06M | ﹤0.01% | 2455 |
|
|
2019
Q3 | $9.2M | Buy |
71,800
+30,300
| +73% | +$4.06M | ﹤0.01% | 2069 |
|
|
2019
Q2 | $5.92M | Sell |
41,500
-31,500
| -43% | -$4.23M | ﹤0.01% | 2490 |
|
|
2019
Q1 | $10.4M | Buy |
73,000
+41,000
| +128% | +$5.35M | ﹤0.01% | 1706 |
|
|
2018
Q4 | $3.97M | Sell |
32,000
-53,700
| -63% | -$7.97M | ﹤0.01% | 2564 |
|
|
2018
Q3 | $14.4M | Buy |
85,700
+42,700
| +99% | +$7.34M | ﹤0.01% | 1598 |
|
|
2018
Q2 | $7.41M | Sell |
43,000
-71,000
| -62% | -$11.6M | ﹤0.01% | 2267 |
|
|
2018
Q1 | $17.2M | Sell |
114,000
-94,000
| -45% | -$13.8M | 0.01% | 1325 |
|
|
2017
Q4 | $28M | Sell |
208,000
-7,900
| -4% | -$1.1M | 0.01% | 1017 |
|
|
2017
Q3 | $31.6M | Buy |
215,900
+35,400
| +20% | +$5.35M | 0.01% | 921 |
|
|
2017
Q2 | $28.1M | Sell |
180,500
-11,200
| -6% | -$1.71M | 0.01% | 912 |
|
|
2017
Q1 | $27.8M | Sell |
191,700
-20,400
| -10% | -$2.66M | 0.01% | 858 |
|
|
2016
Q4 | $23.1M | Sell |
212,100
-6,600
| -3% | -$735K | 0.01% | 942 |
|
|
2016
Q3 | $26.6M | Sell |
218,700
-13,300
| -6% | -$1.79M | 0.01% | 832 |
|
|
2016
Q2 | $32.8M | Buy |
232,000
+10,200
| +5% | +$1.5M | 0.02% | 701 |
|
|
2016
Q1 | $29M | Sell |
221,800
-91,700
| -29% | -$11.4M | 0.02% | 767 |
|
|
2015
Q4 | $44.1M | Buy |
313,500
+75,800
| +32% | +$10.5M | 0.02% | 660 |
|
|
2015
Q3 | $31.6M | Buy |
237,700
+11,800
| +5% | +$2.03M | 0.01% | 877 |
|
|
2015
Q2 | $39.8M | Sell |
225,900
-61,900
| -22% | -$11.1M | 0.02% | 825 |
|
|
2015
Q1 | $49.7M | Sell |
287,800
-126,400
| -31% | -$21.7M | 0.02% | 633 |
|
|
2014
Q4 | $67.8M | Buy |
414,200
+44,100
| +12% | +$7.32M | 0.03% | 568 |
|
|
2014
Q3 | $59.4M | Buy |
370,100
+53,000
| +17% | +$8.15M | 0.02% | 662 |
|
|
2014
Q2 | $46.6M | Sell |
317,100
-108,000
| -25% | -$15M | 0.02% | 745 |
|
|
2014
Q1 | $59M | Buy |
425,100
+278,800
| +191% | +$42M | 0.03% | 548 |
|
|
2013
Q4 | $18.5M | Buy |
146,300
+4,300
| +3% | +$445K | 0.01% | 1423 |
|
|
2013
Q3 | $13.1M | Buy |
142,000
+13,500
| +11% | +$1.09M | 0.01% | 1608 |
|
|
2013
Q2 | $8.83M | Buy |
+128,500
| New | +$7.85M | 0.01% | 1923 |
|
Other funds holding JAZZ
VPM
VCM
EC
Susquehanna International Group's JAZZ Position: Q1 2026 in Review
Susquehanna International Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q1 2026, selling an estimated $156K and leaving 5,914 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #7587.
Susquehanna International Group first reported a position in JAZZ in Q2 2013 and has held it in 47 quarters since. The position peaked at $30.8M in Q1 2014. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Susquehanna International Group held 5,914 shares of Jazz Pharmaceuticals worth $1.12M as of Q1 2026.
- Susquehanna International Group sold 893 Jazz Pharmaceuticals shares in Q1 2026, an estimated $156K.
- Jazz Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7587 holding.
- Susquehanna International Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Jazz Pharmaceuticals position peaked at $30.8M in Q1 2014.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.